Table 1 Summary results for newly discovered loci associated with renal cell carcinoma.
From: Genome-wide association study identifies multiple risk loci for renal cell carcinoma
Locus | SNP * | Closest gene | Position (base pairs) | A/a † | MAF ‡ | Statistics | Discovery (10,784 cases; 20,406 controls) | Replication (3,182 cases; 6,301 controls) | Combined (13,966 cases; 26,707 controls) |
|---|---|---|---|---|---|---|---|---|---|
1p32.3 | rs4381241 | FAF1 | 50907438 | T/C | 0.44 | OR (95% CI) | 1.11 (1.07–1.15) | 1.11 (1.03–1.20) | 1.11 (1.07–1.15) |
P | 1.1 × 10−8 | 8.7 × 10−3 | 3.1 × 10−10 | ||||||
I 2 | 17% | 0% | 0% | ||||||
3p22.1 | rs67311347 | 40533243 | G/A | 0.31 | OR (95% CI) | 0.89 (0.86–0.93) | 0.94 (0.88–1.01) | 0.90 (0.87–0.94) | |
P | 4.7 × 10−8 | 8.8 × 10−2 | 2.5 × 10−8 | ||||||
I 2 | 0% | 56% | 20% | ||||||
3q26.2 | rs10936602 | LRRIQ4 | 169536637 | T/C | 0.27 | OR (95% CI) | 0.90 (0.86–0.94) | 0.91 (0.85–0.98) | 0.90 (0.87–0.93) |
P | 2.7 × 10−7 | 9.7 × 10−3 | 8.8 × 10−9 | ||||||
I 2 | 0% | 48% | 11% | ||||||
8p21.3 | rs2241261 | RHOBTB2/TNFRSF10B | 22876739 | C/T | 0.51 | OR (95% CI) | 1.10 (1.06–1.14) | 1.10 (1.03–1.17) | 1.10 (1.06–1.13) |
P | 3.5 × 10−7 | 2.0 × 10−2 | 5.8 × 10−9 | ||||||
I 2 | 3% | 58% | 21% | ||||||
10q24.33-q25.1 | rs11813268 | OBFC1 | 105682296 | C/T | 0.16 | OR (95% CI) | 1.13 (1.08–1.19) | 1.10 (1.01–1.19) | 1.12 (1.07–1.17) |
P | 5.1 × 10−7 | 2.1 × 10−2 | 3.9 × 10−8 | ||||||
I 2 | 32% | 0% | 0% | ||||||
11q22.3 | rs74911261 | KDELC2 | 108357137 | G/A | 0.02 | OR (95% CI) | 1.42 (1.26–1.61) | 1.38 (1.12–1.69) | 1.41 (1.27—1.57) |
P | 2.1 × 10−8 | 2.6 × 10−3 | 2.1 × 10−10 | ||||||
I 2 | 0% | 0% | 0% | ||||||
rs1800057 | ATM | 108143456 | C/G | 0.02 | OR (95% CI) | 1.40 (1.24–1.59) | 1.30 (1.04–1.62) | 1.38 (1.23–1.53) | |
P | 1.1 × 10−7 | 2.2 × 10−2 | 9.0 × 10−9 | ||||||
I 2 | 14% | 0% | 0% | ||||||
14q24.2 | rs4903064 | DPF3 | 73279420 | T/C | 0.23 | OR (95% CI) | 1.18 (1.13–1.23) | 1.30 (1.21–1.39) | 1.21 (1.16–1.25) |
P | 1.1 × 10−14 | 2.6 × 10−12 | 2.2 × 10−24 | ||||||
I 2 | 28% | 0% | 36% |